When participants state that a phase I trial is intended to benefit them, is this therapeutic misconception?

被引：0
|
作者：
Pentz, Rebecca D.
Pinheiro, Ana M.
Lohani, Minisha
White, Taylor
Dixon, Margie
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
[2] Winship Canc Inst, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e14042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14042
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles
    Sanborn, Sharon L.
    Cooney, Matthew M.
    Dowlati, Afshin
    Brell, Joanna M.
    Krishnamurthi, Smitha
    Gibbons, Joseph
    Bokar, Joseph A.
    Nock, Charles
    Ness, Anne
    Remick, Scot C.
    [J]. INVESTIGATIONAL NEW DRUGS, 2008, 26 (04) : 355 - 362
  • [22] Therapeutic Modulation of the Marrow Microenvironment in MDS: A Phase I Trial of Abaloparatide and Bevacizumab
    Moore, Jozal W.
    Mendler, Jason H.
    Loh, Kah Poh
    Azadniv, Mitra
    O'Dwyer, Kristen M.
    Huselton, Eric J.
    Akwaa, Frank
    Frisch, Benjamin J.
    Strawderman, Myla
    LaMere, Mark W.
    Byun, Daniel K.
    Jasper, Alyssa C.
    Becker, Michael W.
    Liesveld, Jane L.
    Calvi, Laura M.
    [J]. BLOOD, 2022, 140 : 4050 - 4052
  • [23] Characteristics of Participants Enrolled onto a Randomized Controlled Trial of Palliative Care for Patients on Phase I Studies
    Ferrell, Betty R.
    Paterson, Carly L.
    Hughes, Mark T.
    Chung, Vincent
    Koczywas, Marianna
    Smith, Thomas J.
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2017, 20 (12) : 1338 - 1344
  • [24] Safety, Tolerability, and Pharmacokinetics of Zagotenemab in Participants with Symptomatic Alzheimer's Disease: A Phase I Clinical Trial
    Willis, Brian A.
    Lo, Albert C.
    Dage, Jeffrey L.
    Shcherbinin, Sergey
    Chinchen, Louise
    Andersen, Scott W.
    LaBell, Elizabeth S.
    Perahia, David G. S.
    Hauck, Paula M.
    Lowe, Stephen L.
    [J]. JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2023, 7 (01) : 1015 - 1024
  • [25] The therapeutic benefit and toxicity from multiple myeloma phase I trials, 2004 through 2014.
    Malek, Ehsan
    Driscoll, James J.
    Welge, Jeffrey
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Anxiety Shapes Expectations of Therapeutic Benefit in Phase I Trials for Patients With Advanced Cancer and Spousal Caregivers
    Hlubocky, Fay J.
    Sher, Tamara G.
    Cella, David
    Wroblewski, Kristen E.
    Peppercorn, Jeffery
    Daugherty, Christopher K.
    [J]. JCO ONCOLOGY PRACTICE, 2021, 17 (02) : E101 - E110
  • [27] Therapeutic HPV 16/18 vaccine has promising Phase I trial results
    Wilson, Hannah
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (12) : 1373 - 1373
  • [28] Therapeutic HPV 16/18 vaccine has promising Phase I trial results
    Wilson, Hannah L.
    [J]. FUTURE VIROLOGY, 2012, 7 (12) : 1150 - 1150
  • [29] Therapeutic HPV 16/18 vaccine has promising Phase I trial results
    Wilson, Hannah
    [J]. EXPERT REVIEW OF VACCINES, 2012, 11 (12) : 1397 - 1397
  • [30] The therapeutic phase I trial of the recombinant native HIV-1 Tat protein
    Ensoli, Barbara
    Fiorelli, Valeria
    Ensoli, Fabrizio
    Lazzarin, Adriano
    Visintini, Raffaele
    Narciso, Pasquale
    Di Carlo, Aldo
    Monini, Paolo
    Magnani, Mauro
    Garaci, Enrico
    [J]. AIDS, 2008, 22 (16) : 2207 - 2209
12345